Related Experiment Videos
The multiple negative randomized controlled trials in perinatology--why?
1Division of Pulmonary Biology/Neonatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229-3039, USA.
Seminars in Perinatology
|September 27, 2003
Summary
Many perinatal medicine trials fail to show intervention benefits due to weak preliminary data and small patient numbers. Improving trial design requires more robust evidence and better understanding of neonatal disease biology.
Area of Science:
- Neonatal medicine
- Clinical trial design
- Perinatal research
Background:
- Many multicenter trials in perinatal medicine yield negative results, failing to demonstrate intervention benefits.
- Negative trials, while preventing unnecessary treatments, often deviate from the goal of proving intervention efficacy.
Purpose of the Study:
- To investigate the reasons behind the negative outcomes in recent perinatal medicine trials.
- To identify factors limiting the success of clinical trials in this field.
Main Methods:
- Selective review of recent negative multicenter trials in perinatal medicine.
- Analysis of preliminary data, patient cohort sizes, and outcome measures.
Main Results:
- Preliminary evidence, often from small trials or meta-analyses, was frequently not robust or predictive.
- Limited patient numbers, poorly defined primary outcomes, and insufficient understanding of neonatal disease biology contributed to trial failures.
Conclusions:
- Weak preliminary data is a significant factor in the negative results of perinatal trials.
- Improved trial design necessitates stronger foundational evidence and a deeper comprehension of neonatal disease mechanisms.